Drugmakers Court Small Firms in Push to Fill Thinning Pipelines

In an environment where big drug companies are furiously courting biotechnology companies for licensing deals, Ron Cohen is a hot date. The chief executive of Acorda Therapeutics Inc. in Hawthorne, N.Y., is seeking deep-pocket partners to help him develop new treatments for multiple sclerosis and spinal cord injuries. That makes him potentially attractive to a pharmaceutical industry that doesn't have many new drugs of its own to work on.

The Boston Globe (http://www.boston.com/business/globe/articles/2005/03/29/drug_makers_court_small_firms_in_push_to_fill_thinning_pipelines/)